Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)ReceivablesReceivables - NetShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ascendis Pharma A (ASND) Prepaid Assets (2016 - 2025)

Historic Prepaid Assets for Ascendis Pharma A (ASND) over the last 9 years, with Q4 2024 value amounting to $30.2 million.

  • Ascendis Pharma A's Prepaid Assets fell 2722.27% to $30.2 million in Q4 2024 from the same period last year, while for Dec 2024 it was $30.2 million, marking a year-over-year decrease of 2722.27%. This contributed to the annual value of $30.6 million for FY2024, which is 2628.67% down from last year.
  • According to the latest figures from Q4 2024, Ascendis Pharma A's Prepaid Assets is $30.2 million, which was down 2722.27% from $41.5 million recorded in Q4 2023.
  • Ascendis Pharma A's 5-year Prepaid Assets high stood at $41.5 million for Q4 2023, and its period low was $16.7 million during Q4 2020.
  • Over the past 5 years, Ascendis Pharma A's median Prepaid Assets value was $30.2 million (recorded in 2024), while the average stood at $29.9 million.
  • Its Prepaid Assets has fluctuated over the past 5 years, first skyrocketed by 9709.35% in 2020, then crashed by 2722.27% in 2024.
  • Quarter analysis of 5 years shows Ascendis Pharma A's Prepaid Assets stood at $16.7 million in 2020, then soared by 72.99% to $28.9 million in 2021, then grew by 12.11% to $32.4 million in 2022, then rose by 28.27% to $41.5 million in 2023, then dropped by 27.22% to $30.2 million in 2024.
  • Its last three reported values are $30.2 million in Q4 2024, $41.5 million for Q4 2023, and $32.4 million during Q4 2022.